Breast Cancer,TNBC (Triple Negative Breast Cancer) Long-term PROs of Abemaciclib Plus ET For Adjuvant HR+, HER2-, Node-positive, High-risk, EBC Aug 16, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) ctDNA Dynamics in Pts Receiving CAPE for eTNBC With an Incomplete Response to NAT Aug 11, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) PROs in Pts With ER+/HER2- Advanced or mBC Comparing Oral Elacestrant vs SoC ET Aug 11, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Neoadjuvant Atezo + CT Followed by Open-Label Adjuvant Atezo in pts with eTNBC Jul 28, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Durvalumab Combinations in TNBC: Promising Results with D+Paclitaxel (Phase 1b/2 Study) Jun 30, 2023
Breast Cancer,HER2-,TNBC (Triple Negative Breast Cancer) Interim Analysis of Phase III SASCIA Trial on SG in High-Risk HER2-Negative BC Jun 30, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) PD-L1 Expression Predicts Efficacy of PD-1/PD-L1 Inhibitors in Metastatic TNBC Jun 15, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Residual Cancer Burden Impacts EFS in Neoadjuvant Pembrolizumab + Chemo for Early TNBC Jun 15, 2023
